Terms: = Thyroid cancer AND SOX2, MGC2413, 6657, ENSG00000181449, MCOPS3, P48431, ANOP3 AND Prognosis
14 results:
1. SIX1 amplification modulates stemness and tumorigenesis in breast cancer.
Guo L; Li F; Liu H; Kong D; Chen C; Sun S
J Transl Med; 2023 Nov; 21(1):866. PubMed ID: 38031089
[TBL] [Abstract] [Full Text] [Related]
2. Primary Ovarian Small Cell Carcinoma of Pulmonary Type: Analysis of 6 Cases and Review of 31 Cases in the Literatures.
Chen X; Liu HL; Wang JS; Zhao FH
Chin Med Sci J; 2023 Jun; 38(2):130-137. PubMed ID: 37286512
[TBL] [Abstract] [Full Text] [Related]
3. The m6A methyltransferase METTL3 promotes the stemness and malignant progression of breast cancer by mediating m6A modification on sox2.
Xie J; Ba J; Zhang M; Wan Y; Jin Z; Yao Y
J BUON; 2021; 26(2):444-449. PubMed ID: 34076991
[TBL] [Abstract] [Full Text] [Related]
4. SMARCA4/BRG1-Deficient Non-Small Cell Lung Carcinomas: A Case Series and Review of the Literature.
Nambirajan A; Singh V; Bhardwaj N; Mittal S; Kumar S; Jain D
Arch Pathol Lab Med; 2021 Jan; 145(1):90-98. PubMed ID: 33367658
[TBL] [Abstract] [Full Text] [Related]
5. The role of sox2 overexpression in prognosis of patients with solid tumors: A meta-analysis and system review.
Wang S; Liu X; Chen Y; Zhan X; Wu T; Chen B; Sun G; Yan S; Xu L
Medicine (Baltimore); 2020 Mar; 99(13):e19604. PubMed ID: 32221082
[TBL] [Abstract] [Full Text] [Related]
6. circ_0005273 promotes thyroid carcinoma progression by sox2 expression.
Zhang W; Zhang H; Zhao X
Endocr Relat Cancer; 2020 Jan; 27(1):11-21. PubMed ID: 31693489
[TBL] [Abstract] [Full Text] [Related]
7. Oncofetal HLF transactivates c-Jun to promote hepatocellular carcinoma development and sorafenib resistance.
Xiang DM; Sun W; Zhou T; Zhang C; Cheng Z; Li SC; Jiang W; Wang R; Fu G; Cui X; Hou G; Jin GZ; Li H; Hou C; Liu H; Wang H; Ding J
Gut; 2019 Oct; 68(10):1858-1871. PubMed ID: 31118247
[TBL] [Abstract] [Full Text] [Related]
8. The role of SOX family members in solid tumours and metastasis.
Grimm D; Bauer J; Wise P; Krüger M; Simonsen U; Wehland M; Infanger M; Corydon TJ
Semin Cancer Biol; 2020 Dec; 67(Pt 1):122-153. PubMed ID: 30914279
[TBL] [Abstract] [Full Text] [Related]
9. Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis.
Lu G; Li Y; Ma Y; Lu J; Chen Y; Jiang Q; Qin Q; Zhao L; Huang Q; Luo Z; Huang S; Wei Z
J Exp Clin Cancer Res; 2018 Nov; 37(1):289. PubMed ID: 30482236
[TBL] [Abstract] [Full Text] [Related]
10. Non-Coding RNA Pvt1 Promotes cancer Stem Cell-Like Traits in Nasopharyngeal cancer via Inhibiting miR-1207.
Cui M; Chang Y; Fang QG; Du W; Wu JF; Wang JH; Liu ST; Luo SX
Pathol Oncol Res; 2019 Oct; 25(4):1411-1422. PubMed ID: 30141114
[TBL] [Abstract] [Full Text] [Related]
11. OCT4 but not sox2 expression correlates with worse prognosis in surgical patients with triple-negative breast cancer.
Zhang JM; Wei K; Jiang M
Breast Cancer; 2018 Jul; 25(4):447-455. PubMed ID: 29536377
[TBL] [Abstract] [Full Text] [Related]
12. cancer stem-like cell behavior in anaplastic thyroid cancer: A challenging dilemma.
Haghpanah V; Fallah P; Naderi M; Tavakoli R; Soleimani M; Larijani B
Life Sci; 2016 Feb; 146():34-9. PubMed ID: 26772823
[TBL] [Abstract] [Full Text] [Related]
13. Expression of cancer stem cell markers is more frequent in anaplastic thyroid carcinoma compared to papillary thyroid carcinoma and is related to adverse clinical outcome.
Yun JY; Kim YA; Choe JY; Min H; Lee KS; Jung Y; Oh S; Kim JE
J Clin Pathol; 2014 Feb; 67(2):125-33. PubMed ID: 23986551
[TBL] [Abstract] [Full Text] [Related]
14. CD133-expressing thyroid cancer cells are undifferentiated, radioresistant and survive radioiodide therapy.
Ke CC; Liu RS; Yang AH; Liu CS; Chi CW; Tseng LM; Tsai YF; Ho JH; Lee CH; Lee OK
Eur J Nucl Med Mol Imaging; 2013 Jan; 40(1):61-71. PubMed ID: 23081821
[TBL] [Abstract] [Full Text] [Related]